Literature DB >> 25729887

Chemical clearance in infants and children with Acid reflux in the physiologic range.

Frederick W Woodley1, Rodrigo Machado, Carlo Di Lorenzo, Hayat Mousa.   

Abstract

BACKGROUND AND AIM: We reported that chemical clearance (CC) of acid gastroesophageal reflux (AGER) is relatively prolonged in children with cystic fibrosis (CF). Disparity in CC values within our CF cohort sparked curiosity as to what CC looks like in infants and children with AGER in the physiologic range. The aim of the study was to assess CC in infants and children with normal AGER.
METHODS: Impedance-pH tracings from our database for infants (≤ 12 months) and children (>12 months-18 years) were manually scanned for 2-phase AGER episodes. Tracings were excluded for patients who had AGER Indices >3% (children) or >6% (infants), had positive GER-symptom associations, were on antireflux medications, had a fundoplication, or had impedance studies shorter than 18 hour. In addition to medians (25%-75% interquartile range), we calculated the 95th percentile for the CC duration and the fifth percentile for the CC rate.
RESULTS: Two-phase AGER episodes were detected in 44 infants and 60 children. The median CC duration was 64.3 seconds (51.0-91.6 seconds) for infants and 37.5 seconds (27.7-52.4 seconds) for children. The median CC rate was 0.0622 pH units/second (PU/second) (0.0354-0.0946 PU/second) for infants and 0.0928 PU/second (0.0631-0.2057 PU/second) for children. The CC duration at the 95th percentile was 148.5 seconds for infants and 114.4 seconds for children. The CC rate at the fifth percentile was 0.0088 PU/second for infants and 0.0465 PU/second for children.
CONCLUSIONS: We report reference values for CC in infants and children who have normal acid reflux. These values should not be used as "cutoff values" because they were derived from infant and children cohorts that did not include individuals with intermediate AGER.

Entities:  

Mesh:

Year:  2015        PMID: 25729887     DOI: 10.1097/MPG.0000000000000777

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

Review 1.  Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.

Authors:  Steven L Ciciora; Frederick W Woodley
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 2.  Impedance Testing in Esophageal Atresia Patients.

Authors:  Maheen Hassan; Hayat Mousa
Journal:  Front Pediatr       Date:  2017-04-25       Impact factor: 3.418

3.  Gastroesophageal reflux in cystic fibrosis across the age spectrum.

Authors:  Frederick W Woodley; Don Hayes; Benjamin T Kopp; Melissa Moore-Clingenpeel; Rodrigo Strehl Machado; Christopher J Nemastil; Sudarshan Jadcherla; Carlo Di Lorenzo; Ajay Kaul; Hayat Mousa
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-16

4.  Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during Chemical Clearance of Acid Reflux.

Authors:  Frederick W Woodley; Melissa Moore-Clingenpeel; Rodrigo Strehl Machado; Christopher J Nemastil; Sudarshan R Jadcherla; Don Hayes; Benjamin T Kopp; Ajay Kaul; Carlo Di Lorenzo; Hayat Mousa
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.